The Beecham Group plc was a Great Britain pharmaceutical company. It was once a constituent of the FTSE 100 Index. Founded by Thomas Beecham who opened the first factory in St Helens, Lancashire in 1859, Beecham focused on marketing the business by advertising in newspapers and using a network of wholesale agents in northern England and in London, rapidly building up the business. In August 1859 he created the slogan for Beecham's Pills: "Worth a guinea a box", considered to be the world's first advertising slogan, which helped the business become a global brand.
Beecham, after having merged with American pharmaceutical company SmithKline Beckman to become SmithKline Beecham, merged with Glaxo Wellcome to become GlaxoSmithKline (GSK). GSK (and later, Haleon) still uses the Beechams brand name in the UK for its over-the-counter common cold and influenza relief products.
He later became a travelling salesman or peddler full time. His first product was Beecham's Pills, a laxative, in 1842. Subsequent success enabled him to open a shop in Wigan in 1847. Thomas Beecham at Oxford Dictionary of National Biography Beecham opened its first factory in 1859, in St Helens, Lancashire, for the rapid production of medicines. In August 1859, Beechams created a slogan for Beecham's Pills: "Beechams Pills: Worth a guinea a box", which is considered to be the world's first advertising slogan. First appearing in the St Helens Intelligencer, the Beechams adverts would appear in newspapers all over the world, helping the company become a global brand. The phrase was first said to be uttered by a satisfied lady purchaser from St Helens, the founder's home town. Under the founder's son, Sir Joseph Beecham, 1st Baronet (1848–1916), the business expanded, but remained a patent medicine company and engaged in little research.
In 1943, the company decided to focus more on improving research and built Beecham Research Laboratories at Brockham Park, Surrey. In 1945, the company was renamed Beecham Group Ltd. in 1953, Beecham acquired C.L. Bencard, which specialised in allergy vaccines.
Beecham Research Laboratories opened a four-acre site around October 1969 in Harlow in Essex, with 80 staff. Herts and Essex Observer Friday 15 August 1969, page 12 In 1997 this became the SmithKline Beecham New Frontiers Science Park.
The company continued to add products, and acquire other companies, through the 1970s and 1980s. In 1971, the S. E. Massengill Company was acquired. Beecham launched Amoxil (amoxicillin) in 1972, which went on to become one of the most widely prescribed antibiotics.
In 1973, Aquafresh toothpaste was launched, and in 1977, the Dyclonine brand was acquired. Augmentin, an antibiotic used to treat an array of bacterial infections, was introduced in 1981. J.B. Williams Co., Inc. was acquired from Nabisco in 1982 for US$100 million (approximately £59 million), which included brands Aqua Velva, Geritol, and Sominex − the U.S. formulation − along with others.
As the turn of the century approached, there were more significant mergers. In 1989, The Beecham Group plc and SmithKline Beckman merged to form SmithKline Beecham plc. In 2000, SmithKline Beecham and GlaxoWellcome merged to form GSK plc.
A history of the company, Beechams, 1848–2000: From Pills to Pharmaceuticals, written by Thomas Anthony Buchanan Corley, was published in 2011.
Expansion and diversification
Antibiotics
Later history
Products
Consumer healthcare
Pharmaceuticals
See also
External links
|
|